Search is Powered by Google
Medical Devices / Diagnostics News

Automated External Defibrillators - FDA Classifies As A Class I Action An Urgent Medical Device Correction By Physio-Control

Main Category: Medical Devices / Diagnostics
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 15 Sep 2008 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
<A HREF="http://www.mlclick.com/mlcl.php?aid=B1F0C1D32D0A9D9782E1C424695C5C0C" target="_blank"><IMG SRC="http://www.mlclick.com/mltr.php?aid=B1F0C1D32D0A9D9782E1C424695C5C0C&b=2" WIDTH="300" HEIGHT="250" BORDER="0" alt="41st World Forum for Medicine, International Trade Fair with Congress"></A>


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT) announced the FDA has classified as a Class I action the company's recently initiated and completed voluntary urgent medical device recall of 249 fully automatic LIFEPAK CR Plus automated external defibrillators (AEDs). Certain fully automated devices manufactured from May 2004 through April 2007 are mis-configured with the software intended for semi-automatic AEDs. With this configuration set up, if the responder is instructed to press the shock button to deliver therapy, they will not be able to locate the shock button because it is covered in the fully automated device. In this situation, it is possible that therapy could be delayed or not delivered at all; possibly resulting in death. There has been one patient related complaint associated with this issue.

As of September 2, 2008, the company has notified all affected customers and shipped replacement devices at no charge. During the brief interval while customers awaited receipt of replacement devices, Physio-Control recommended that customers with the identified, affected defibrillators either remove the affected AED(s) from service or remove and discard the shock button cover (instructions provided).

If customers have questions or would like additional information they should contact Physio-Control Technical Support. Customers may also visit the company's website at http://www.physio-control-notices.com/config for more information or to enter the serial numbers of their devices to determine if they are affected by this action.

About the LIFEPAK CR Plus AEDs

The LIFEPAK CR Plus automated external defibrillators (AEDs) are battery operated and portable. These AEDs are placed in public access environments such as schools, airports, city halls, retail locations and workplaces. Anyone with minimal CPR/AED training can use an AED to provide a defibrillation shock to someone in sudden cardiac arrest.

About Physio-Control

Physio-Control is located in Redmond, Wash. Physio-Control pioneered defibrillation technology over 50 years ago. With more than 650,000 LIFEPAK® defibrillators distributed worldwide, the company is the world's leading provider of external defibrillators for the treatment of sudden cardiac arrest. To find out more about Physio-Control, go to http://www.physio-control.com.

Physio-Control




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA Approves KAPIDEX (dexlansoprazole) Delayed-Release Capsules For The Treatment Of GERD
03 Feb 2009
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved KAPIDEX™ (dexlansoprazole)...


Naps Aren't Just for Kids Anymore
Naps Aren't Just for Kids Anymore

A power nap may be the answer to the mid-day slump. Research suggests naps improve productivity, mental function, and motor function. They also may improve cardiovascular health.

more videos are available in our health videos section.